Skip to content
DE

What Are the 14 Tests in a Comprehensive Metabolic Panel?

Clinical review pending

What glucose, electrolytes, kidney and liver markers in a CMP can tell you, and how to interpret the pattern rather than one flagged number.

A hand holds an open blank book with three colored windows.

What the 14 CMP measurements tell you

A comprehensive metabolic panel, or CMP, measures 14 substances in a blood sample. It brings together several kinds of information rather than producing a single score for metabolic health. Glucose measures blood sugar. Sodium, potassium, chloride, and carbon dioxide, usually reported as total CO2 and largely reflecting bicarbonate, help assess fluid and acid-base balance. Source Source

Blood urea nitrogen, or BUN, and creatinine are waste products used to help assess kidney filtration. The liver-related measurements include alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin. Different patterns can suggest liver-cell injury, changes in bile flow, or other causes. These markers are not all specific to the liver: AST can also come from muscle, and ALP can come from bone. Source Source

Albumin and total protein add information about circulating proteins. Albumin is made in the liver, but its blood concentration also reflects inflammation, fluid balance, and protein losses. It should not be used on its own to diagnose poor nutrition. Calcium completes the 14 measurements. It is important for nerve, muscle, and cellular signaling, although a blood calcium result is not a direct measure of bone strength. Source Source Source

Each result captures a different part of the picture. Reading them together can help identify a useful next question, such as whether an unusual value reflects an organ problem, a medication, dehydration, or a temporary change. A flagged result usually needs context rather than an immediate diagnosis.

Reference ranges and what is right for you

Many laboratory reference intervals describe the middle 95% of an apparently healthy comparison population. Some clinical decision thresholds, such as those used to diagnose diabetes, are established differently. A result within a reference interval is not a guarantee of health, but neither is a value near its edge automatically a sign that something needs “optimization.”

A commonly used fasting glucose range is 70–99 mg/dL. A 2005 study of young men found that higher glucose within the nondiabetic range was associated with greater later diabetes risk: risk increased across categories beginning at 87 mg/dL compared with the lowest category, below 81 mg/dL. That observational finding does not establish 85 mg/dL as a diagnostic cutoff for insulin resistance or a treatment target for everyone. Risk also depends on factors such as family history, body composition, and triglycerides. Source Source

Electrolyte concentrations are tightly regulated. Example adult laboratory ranges are sodium 136–145 mEq/L, potassium 3.5–5.1 mEq/L, chloride 98–107 mEq/L, and total CO2 22–29 mEq/L. Laboratories may use different intervals, so the range on the actual report matters. The size of a change, how quickly it developed, and the person’s symptoms help determine its significance. Source

Example creatinine intervals are 0.7–1.3 mg/dL for men and 0.6–1.1 mg/dL for women, but interpretation also depends on muscle mass, age, and laboratory method. A value near the upper limit is not by itself proof of early kidney disease. Creatinine is commonly used to estimate glomerular filtration rate, or eGFR; urine albumin testing may provide additional information about kidney damage. A consistent change from someone’s usual result can be more informative than a single borderline number. Source Source Source

Personal trends can be useful, particularly when a condition or treatment is being monitored. The aim is to answer a clinical question, not to move every measurement toward an arbitrarily chosen point inside its reference interval.

What high CMP results can mean

Fasting glucose of 100–125 mg/dL falls in the ADA’s impaired fasting glucose, or prediabetes, range. A fasting value of 126 mg/dL or above meets a diabetes threshold, generally requiring confirmation unless hyperglycemia is unequivocal. These thresholds apply to a fasting measurement; a sample taken after eating needs a different interpretation. BUN above a laboratory’s upper limit, often around 20 mg/dL, together with elevated creatinine may suggest impaired kidney function, but dehydration and other factors can also raise these results. Source Source Source

High liver enzymes have several possible explanations. ALT may rise with medication-related injury, alcohol-related injury, or metabolic dysfunction-associated steatotic liver disease. AST may increase after muscle injury or strenuous exercise as well as with liver injury. An elevated ALP result can relate to the bile ducts or to bone. The pattern, other tests, symptoms, and medication history help distinguish these possibilities. Source Source Source

Electrolyte results also need to be read together. High sodium often reflects too little water relative to sodium, sometimes involving impaired renal water handling. High potassium may accompany impaired kidney function or certain medications; sample-related problems can also need consideration. Chloride often changes alongside sodium. High total CO2 can occur in metabolic alkalosis or as compensation for a respiratory acid-base disturbance. It does not, by itself, identify a specific lung or kidney disorder. Source Source Source Source

High albumin or total protein can result from dehydration. High calcium may be associated with an overactive parathyroid gland, some cancers, or excessive vitamin D exposure, among other causes. Total calcium is also affected by albumin concentration. Other laboratory results and the clinical situation determine whether further assessment, including ionized calcium in some circumstances, is useful. Source Source

What low CMP results can mean

Glucose below 70 mg/dL is an important low-glucose threshold, especially for people taking diabetes medication. Possible causes include glucose-lowering drugs, alcohol-related effects, and less commonly an insulin-secreting tumor. An unexpected low laboratory value still needs interpretation alongside symptoms and the circumstances of the sample. Low BUN may occur with reduced liver urea production, low protein intake or malnutrition, or excess body water. Source Source Source

Low ALT or AST is usually less informative than an elevation. These results are not a reliable standalone test for nutritional deficiency or severe liver failure. Conversely, relatively normal aminotransferases do not exclude advanced liver disease. Low bilirubin is usually not clinically significant. A persistently low ALP is a different finding and may deserve a separate explanation rather than being grouped with all other “low liver enzymes.” Source

Electrolyte abnormalities can affect nerves, muscles, and the heart. Low sodium, called hyponatremia, can cause confusion or seizures when severe or rapidly developing; excess water relative to sodium and some medications are among its causes. Low potassium can affect muscle function and heart rhythm. Low chloride often occurs with other fluid or electrolyte changes and can also accompany losses from vomiting. The symptoms and degree of change matter more than the label “low” alone. Source Source Source Source

Low total protein or albumin can accompany liver disease, protein loss through the kidneys or gut, and chronic illness with inflammation. Malnutrition may coexist, but albumin alone does not establish it. Low total calcium can occur with vitamin D deficiency, parathyroid disorders, or magnesium deficiency. It may also reflect low albumin while the physiologically active ionized calcium is normal, which is why the results need to be interpreted together. Source Source

How the 14 CMP tests are performed

A CMP usually requires one blood sample drawn from a vein in the arm. If the clinician wants fasting glucose, the preparation commonly involves 8–12 hours without food or caloric drinks; follow the laboratory’s instructions. Plain water is generally allowed. A CMP can also be ordered without fasting, so fasting is not an automatic requirement of every panel. Source Source

Automated laboratory instruments measure the components from the sample. Results may be available the same day or within roughly 24–48 hours, depending on the laboratory and setting. Turnaround time is a service detail, not a measure of the test’s medical usefulness.

The timing and frequency depend on why the panel was ordered. Diabetes, kidney or liver disease, an abnormal earlier result, or medication monitoring can justify repeat testing. The cited diabetes guidance does not establish that every healthy adult needs an annual CMP. A morning draw after an overnight fast may be convenient when fasting glucose is specifically required. Source

Ask for preparation instructions that account for your usual medications, particularly if fasting could affect diabetes treatment. Do not stop a prescribed medicine independently to obtain a “better” result. The clinician needs to know which medications and supplements you take so that the result can be interpreted in context.

What can affect the results?

Food intake affects several measurements. A carbohydrate-containing meal can raise glucose, while a high-protein diet may raise BUN. Dehydration can concentrate blood constituents without representing equivalent damage to the organs associated with those markers. Collection conditions matter too: the cited Lippi study examined short-term venous stasis during blood collection, not ordinary dehydration or meal effects. Its findings illustrate a separate source of variation. Source Source

Exercise can temporarily change laboratory results. A strenuous session may raise AST, ALT, or creatinine through muscle-related effects, whereas regular exercise can improve insulin sensitivity over time. Mention unusual recent exertion when discussing an unexpected result; a single sample does not distinguish every cause. Source Source

Medications can alter the pattern as well. Diuretics affect electrolytes, statins can affect liver enzymes, and ACE inhibitors can raise potassium. Nonsteroidal anti-inflammatory drugs, or NSAIDs, can affect kidney function, particularly in susceptible people. These are reasons to review the medication list, not instructions to discontinue treatment. Source Source Source Source

Age and muscle mass complicate creatinine interpretation. Kidney filtration often declines with age, which can raise creatinine, while loss of muscle reduces creatinine production and can conceal a decline in filtration. The cited study of people with primary neuromuscular disease illustrates the limitations of creatinine in low-muscle-mass populations; it does not establish one correction that applies to every older adult. Source Source

When other biomarkers add useful information

A CMP does not answer every metabolic question. Hemoglobin A1c, or HbA1c, estimates average glucose exposure over approximately three months and can complement the single-time-point glucose measurement. Its interpretation also depends on circumstances that affect red blood cells or hemoglobin, so agreement between tests is considered rather than assumed. Source

Insulin measurements can help answer selected questions about glucose regulation, but glucose and insulin values alone do not reliably classify every person’s diabetes or determine its stage. A high insulin level alongside high glucose may be consistent with insulin resistance; a lower level needs context rather than automatically meaning that diabetes has progressed. Routine insulin testing is not required for most people’s diabetes assessment. Magnesium can be useful when investigating unexplained low potassium or calcium because their regulation is connected. Source Source Source

Thyroid testing, such as TSH, may help when symptoms or a laboratory pattern suggest a thyroid disorder. CRP can indicate inflammation, but it cannot determine where that inflammation is or reliably distinguish “inflammation” from direct liver-cell injury. Those processes can overlap. Neither test should be added simply because it is absent from the standard panel. Source Source Source

A lipid panel answers another set of questions. Triglycerides and glucose can be associated with insulin resistance, while a metabolic syndrome assessment also considers findings such as waist circumference, blood pressure, and HDL cholesterol. A CMP alone does not diagnose that syndrome, and adding a large collection of tests is not automatically more informative than selecting the ones relevant to the person. Source Source

What is useful about testing these values together?

A well-chosen panel can reveal an abnormality before symptoms appear and provide a starting point for investigation. For example, the Tirosh study linked higher fasting glucose within the nondiabetic range to later diabetes in young men. It did not test the overall effectiveness of routine CMP screening or diagnose early insulin resistance from a particular glucose result. A rising creatinine trend can also prompt assessment of kidney function, provided changes in muscle mass, hydration, and medication are considered. Source

One sample can supply information about several systems, which is convenient when those measurements are clinically indicated. That convenience is different from evidence that universal annual CMP testing is cost-effective or prevents later specialist care. The cited USPSTF statement concerns screening for prediabetes and type 2 diabetes in defined populations; it is not a recommendation to screen everyone with all 14 CMP measurements. Source

Follow-up results may help guide action. Diabetes prevention research supports lifestyle intervention for people at increased risk, but a falling glucose value is not the only measure of benefit. Kidney monitoring may help assess treatment, while creatinine can change for reasons other than improvement or deterioration; for example, some kidney-protective treatment can cause an initial creatinine rise. Blood pressure, urine findings, eGFR trends, and the treatment context matter. Source Source Source

A previous result can be a useful comparison when a new health question arises. The value of a personal baseline lies in interpreting a meaningful change, not in assuming that more frequent testing is always better.

Putting the panel in context

The 14 measurements make most sense as a pattern. Symptoms, medical history, medications, preparation, and previous results help determine what that pattern means. Further tests are useful when they answer a specific unresolved question, rather than because the standard panel is inherently incomplete.

Frequently asked questions

What conditions can a CMP point to?

It can provide clues about diabetes, kidney disease, liver injury or impaired bile flow, and fluid, electrolyte, or other metabolic disturbances. It does not confirm every possible diagnosis, and a result outside the laboratory range can have temporary or non-disease explanations. The next step depends on the overall pattern and clinical context.

What is the difference between a basic and comprehensive metabolic panel?

A basic metabolic panel, or BMP, contains eight measurements: glucose, calcium, sodium, potassium, chloride, total CO2, BUN, and creatinine. The CMP adds six: ALT, AST, ALP, bilirubin, albumin, and total protein. These additions broaden the assessment, especially of liver-related patterns and blood proteins. Source

Do you need to fast for the 14 CMP tests?

Not always. If fasting glucose is requested, instructions commonly specify 8–12 hours without food or caloric drinks, with plain water allowed. Avoid chewing gum if the fasting instructions say to do so, and check medication instructions beforehand. The preparation depends on what the clinician intends to learn from the sample.

Does a CMP include cholesterol?

No. Cholesterol and triglycerides are measured in a separate lipid panel. The two panels may be ordered together when both are relevant, but they answer different questions and neither is automatically required whenever the other is ordered.

ALT and AST can rise with liver-cell injury, although AST also comes from other tissues. ALP can reflect bile-duct or bone processes. Bilirubin helps assess the handling of a breakdown product of red blood cells. Albumin and total protein add information about circulating proteins and, in context, protein production or loss. They are not a standalone nutrition assessment.

How often should a CMP be checked?

There is no single schedule for everyone. The reason for testing, previous results, medical conditions, and medications determine whether and when to repeat it. Three- to six-month checks may be appropriate in some monitoring situations, while other situations call for a much shorter or longer interval. A blanket annual recommendation for all healthy adults is not established by the cited diabetes screening guidance.

What can change the results?

Recent meals, unusually strenuous exercise, hydration, medications, and blood-collection conditions can all matter. Diuretics, statins, ACE inhibitors, and NSAIDs are examples of medicines that may affect relevant measurements. Following the agreed preparation and sharing an accurate medication history helps make the result interpretable.

Why does the pattern matter more than one number?

The organ most commonly associated with a marker is not always the source of a change. AST can rise after muscle injury rather than liver injury. Low muscle mass can keep creatinine deceptively low despite reduced kidney filtration; a creatinine increase is not required for that masking effect. Looking at the full pattern and changes over time helps identify which explanations need investigation and which may be temporary.

Sources and references

Additional clinical references: https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/ https://doi.org/10.2337/dc26-S002 https://pubmed.ncbi.nlm.nih.gov/33125793/ https://doi.org/10.2337/dci23-0036 https://pmc.ncbi.nlm.nih.gov/articles/PMC10735173/ https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf https://medlineplus.gov/lab-tests/c-reactive-protein-crp-test/

Related pages from the source publisher (commercial material, not evidence for clinical thresholds): Related page Related page Related page Related page Related page

Further reading

The original guide provides additional background on the panel.